Israeli Pharmaceutical Company to Offer Generic Viagra Pill, Cost to be Reduced by 90%
×
[contact-form-7 404 "Not Found"]
by Zach Pontz
Viagra. Photo: Wikipedia.
Israel-based Teva Pharmaceutical Industries Ltd. is set to launch a generic form of the impotence-alleviating pill Viagra in Europe, Globes reported Friday.
The patent held by Pfizer Inc., which is located in the United States, expires in the UK and other countries this weekend, allowing Teva to launch the generic version. Teva will call their version Sildenafil. The cost of the pill will be reduced considerably, from £10 to £1 in the UK for instance.
However, Teva will be unable to provide Sildenafil to the U.S. market after a court ruled that the patent there is valid until 2020.
Share this Story:
Let your voice be heard!
Join the Algemeiner
Trending
-
Iran Warns Israel Not to ‘Test Its Resolve,’ Says ‘Unacceptable’ for Gulf Arabs to Assist Jewish State
-
Sinai Temple in Los Angeles Launches Program to Help Jewish Students Combat Antisemitism
-
Columbia University Kicks Off Campus Tour of Oct. 7 Hamas Sexual Abuse Doc Hosted by Former Meta COO Sheryl Sandberg
-
‘Bring the War Home’: Anti-Israel Ivy League Students Vandalize Campuses on Oct. 7 Anniversary
-
Leading Anti-Israel Group Slammed for Mentioning Dead Israelis in Oct. 7 Statement